Baxter international inc. (BAX)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07
Cash flows from operations
Net income

1,011

1,546

602

4,965

968

2,497

2,012

2,326

2,256

1,427

2,215

2,025

1,721

Adjustments to reconcile net income to cash flows from operations:
Loss from discontinued operations, net of tax

0

-6

-7

-1

575

2,040

1,697

-

-

-

-

-

-

Depreciation and amortization

789

771

750

800

759

792

635

712

670

685

638

631

581

Realized excess tax benefits from stock issued under employee benefit plans

-

-

-

39

7

15

21

24

21

41

96

112

-

Infusion pump and other product-related charges

-

-

-

-

-28

93

17

-

-

588

27

125

-

Losses (gains) related to contingent payment liabilities

-

-

-

-

-

-

-

-108

-

-

-

-

-

Pension settlement charges

-755

-1

-2

-

-

-

-

-

-

-

-

-

-

Deferred income taxes

-310

-263

211

-302

-50

-117

-185

-17

172

76

267

280

126

Stock compensation

122

115

107

115

126

126

122

130

119

120

140

146

136

Impairment charge

-

-

-

-

-

-

-

-

-

-

-

31

-

Litigation-related charge

-

-

-

-

-

-

-

-

-

62

0

-

-

Exit and other charges

-

-

-

-

-

-

-

-

-

-

-

-

70

Acquired in-process research and development

-

-

-

-

-

-

-

-

-

-

0

19

61

Net periodic pension benefit and other postretirement costs

22

39

123

116

227

219

308

477

255

-

-

-

-

Business optimization charges

-

-

-

-

-

-

149

150

192

257

79

-

-

Asset impairment and other charges

-

-

-

-

-

-

-

-

182

140

54

-

-

Restructuring charges

-

-

-

285

130

-6

-

-

-

-

-

-

-

Intangible asset impairment

31

0

0

-

-

-

-

-

-

-

-

-

-

Net realized gains on Baxalta common stock

-

-

-

4,387

-

-

-

-

-

-

-

-

-

Average wholesale pricing litigation charge

-

-

-

-

-

-

-

-

-

-

-

-

56

Other

-115

-50

-38

-246

-42

-19

73

-66

-32

-57

-1

40

-19

Accounts receivable, net

65

12

-30

-15

4

93

-16

41

229

122

167

98

-278

Inventories

-4

197

-76

-80

118

143

49

129

315

-20

60

163

-211

Accounts payable and accrued liabilities

-212

60

11

-197

236

-37

175

40

98

26

-55

-239

1

Business optimization payments

-

-

-

164

89

124

94

283

347

110

75

50

-27

Other

-152

-99

-227

90

-364

-17

-26

-193

-247

-182

-

-

-

Cash flows from operations – continuing operations

2,110

2,017

1,730

1,624

1,253

1,154

1,289

-

-

-

-

-

-

Cash flows from operations – discontinued operations

-6

0

-16

30

518

2,061

1,909

-

-

-

-

-

-

Other, including pension contributions

-

-

-

-

-

-

-

-

-

-

59

120

88

Cash flows from operations

2,104

2,017

1,714

1,654

1,771

3,215

3,198

3,106

2,817

3,003

2,909

2,515

2,305

Cash flows from investing activities
Capital expenditures

696

659

616

719

911

925

706

1,161

960

963

1,014

954

692

Acquisitions and investments, net of cash acquired

418

268

686

48

34

95

3,673

515

590

319

156

99

112

Other investing activities, net

14

11

10

37

84

99

31

107

123

18

24

-60

-499

Cash flows from investing activities – continuing operations

-

-

-

-730

-861

-921

-4,348

-

-

-

-

-

-

Cash flows from investing activities – discontinued operations

-

-

-

15

-946

-621

-1,014

-

-

-

-

-

-

Cash flows from investing activities

-1,100

-916

-1,292

-715

-1,807

-1,542

-5,362

-1,569

-1,427

-1,264

-1,146

-993

-305

Cash flows from financing activities
Issuances of debt

1,661

0

665

1,641

6,868

41

3,636

1,037

506

658

872

671

584

Borrowings under revolving credit facility

222

0

0

-

-

-

-

-

-

-

-

-

-

Payments of debt and capital lease obligations

-

-

-

1,381

3,786

1,029

540

22

23

567

199

950

635

Debt extinguishment costs

-

-

-

16

114

-

-

-

-

-

-

-

-

Net increase in debt obligations with original maturities of three months or less

-

-

-

-300

-575

875

-

-250

250

-

-200

200

-

Transfer of cash and equivalents to Baxalta

-

-

-

-

2,122

-

-

-

-

-

-

-

-

Cash dividends on common stock

423

376

315

268

910

1,095

1,023

804

709

688

632

546

704

Proceeds from stock issued under employee benefit plans

356

258

347

286

193

369

508

512

448

381

381

-680

-639

Purchases of treasury stock

1,270

2,452

564

292

-

550

913

1,480

1,583

1,453

1,216

1,986

1,855

Other financing activities, net

-48

-33

-40

6

-35

-13

-23

-108

-26

-47

-18

-

-

Cash flows from financing activities

498

-2,603

93

-324

-481

-1,402

1,645

-1,115

-1,137

-1,716

-1,012

-1,931

-1,971

Effect of foreign exchange rate changes on cash and cash equivalents

-5

-63

102

-27

-195

-79

-18

-57

-33

-124

-96

1

25

Increase in cash and cash equivalents

1,497

-1,565

617

588

-712

192

-537

365

220

-101

655

-408

54

Non-cash investing and financing activities
Net proceeds on Retained Shares transactions

-

-

-

4,387

-

-

-

-

-

-

-

-

-

Payment of obligations in exchange for Retained Shares

-

-

-

3,646

-

-

-

-

-

-

-

-

-

Exchange of Baxter shares with Retained Shares

-

-

-

611

-

-

-

-

-

-

-

-

-

(Increases) decreases in the accrual for capital expenditures

-

-

-

-28

-

-

-

-

-

-

-

-

-

Other supplemental information
Interest paid, net of portion capitalized

103

94

80

99

178

208

200

135

88

112

113

159

119

Income taxes paid

294

301

253

500

466

726

648

415

357

353

246

247

304